Psychiatrists' attitude to antipsychotic depot treatment in patients with first-episode schizophrenia.
about
Impact of long-acting injectable antipsychotics on medication adherence and clinical, functional, and economic outcomes of schizophreniaProfile of paliperidone palmitate once-monthly long-acting injectable in the management of schizophrenia: long-term safety, efficacy, and patient acceptability - a reviewLong-acting antipsychotic drugs for the treatment of schizophrenia: use in daily practice from naturalistic observations.A qualitative study of the attitudes of patients in an early intervention service towards antipsychotic long-acting injections.Paliperidone extended-release: does it have a place in antipsychotic therapy?Antipsychotic therapeutic drug monitoring: psychiatrists' attitudes and factors predicting likely future use.Role of long-acting injectable second-generation antipsychotics in the treatment of first-episode schizophrenia: a clinical perspective.Treatment adherence with early prescription of long-acting injectable antipsychotics in recent-onset schizophrenia.Long-acting injectable antipsychotics for first-episode schizophrenia: the pros and cons.Once-monthly paliperidone palmitate in recently diagnosed and chronic non-acute patients with schizophrenia.The knowledge and attitudes of psychiatrists towards antipsychotic long-acting injections in Nigeria.Should we listen and talk more to our patients?Should long-acting (depot) antipsychotics be used in early schizophrenia? A systematic review.Patients' and clinicians' attitude towards long-acting depot antipsychotics in subjects with a first episode of psychosis.Three-month paliperidone palmitate - a new treatment option for schizophrenia.Barriers to the Use of Long-Acting Injectable Antipsychotics in the Management of Schizophrenia.Indications for and use of long-acting injectable antipsychotics: consideration from an inpatient setting.Treatment patterns and health care resource utilization in a 1-year observational cohort study of outpatients with schizophrenia at risk of nonadherence treated with long-acting injectable antipsychotics.Psychiatrists' awareness of partial- and non-adherence to antipsychotic medication in schizophrenia: results from the Australian ADHES survey.Safety and efficacy of paliperidone palmitate 1-month formulation in Chinese patients with schizophrenia: a 25-week, open-label, multicenter, Phase IV study.Long-acting injectable antipsychotics in first-episode schizophrenia.Patient and Health Care Provider Perspectives on Long Acting Injectable Antipsychotics in Schizophrenia and the Introduction of Olanzapine Long-Acting Injection.Combining depot antipsychotic with an assertive monitoring programme for treating first-episode schizophrenia in a resource-constrained setting.Acceptance rate of long-acting injection after short information: a survey in patients with first- and multiple-episode psychoses and their caregivers.
P2860
Q24597701-93C7C990-C072-4FD1-806B-92E7D5F2406EQ28084899-68B76E79-2407-4265-B69F-87D7BBE0BF7BQ34386881-C9F590B3-7D5C-462A-9598-E38B70A59675Q34418852-58ECEA91-383F-4D80-8EF6-4116A1FB6183Q34712339-E567846D-1DFB-4104-87EE-706FB6DB8DFBQ35948858-C625EBCA-62C6-474D-BD8D-CF7808C12EDDQ36168916-2EDBD8BC-E204-4853-BC53-5257F1CCE557Q36169091-8763ED3A-9114-48C5-9BDF-8C4E74525969Q36183650-8DDFC959-CF3F-4346-8B8F-AF17D8B024B9Q36981526-2C7F6873-273F-4978-B3BE-6CA0E3C3A319Q37079053-F5EDCE54-5456-4F54-913F-A198CEC0EF45Q37236159-4373210A-42CC-40E9-BCD9-9EE0B322C536Q38064842-C80E64EF-3067-4377-8243-3FDEBE2EEB5FQ38156171-90EF157C-6B58-40D2-8563-3850A3498D9CQ38840088-C26B30BF-768A-406B-8780-F0E471E1EFC5Q38851847-A32D53E8-32D3-4DE6-830A-F600F027F9B6Q39128141-50B652F5-56E0-42A8-95C4-0F743AC01510Q40427430-1F3DD1AC-3CFD-419C-B8AA-FE28011E3A45Q41201128-F832DCF6-A4F1-4D40-9694-1E927001A793Q41283940-34DE01AA-C203-4801-AC06-C80CCB3B3DD8Q41991738-916E0CC6-6177-48D7-90B7-351735595A63Q42520005-5CC4E817-D25E-4AAE-BB23-546C45EF7128Q48081253-8498A00E-876A-411B-BD5E-0A3ADCEA12D1Q53202420-1ABA69F7-754E-41E0-8F30-424105AA4950
P2860
Psychiatrists' attitude to antipsychotic depot treatment in patients with first-episode schizophrenia.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Psychiatrists' attitude to ant ...... h first-episode schizophrenia.
@en
Psychiatrists' attitude to ant ...... h first-episode schizophrenia.
@nl
type
label
Psychiatrists' attitude to ant ...... h first-episode schizophrenia.
@en
Psychiatrists' attitude to ant ...... h first-episode schizophrenia.
@nl
prefLabel
Psychiatrists' attitude to ant ...... h first-episode schizophrenia.
@en
Psychiatrists' attitude to ant ...... h first-episode schizophrenia.
@nl
P2093
P1433
P1476
Psychiatrists' attitude to ant ...... h first-episode schizophrenia.
@en
P2093
P304
P356
10.1016/J.EURPSY.2009.12.020
P407
P577
2010-06-08T00:00:00Z